Iovance Biotherapeutics Stock Price - IOVA

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Pre-Market
Last Trade
Last: $ 21.50 ▲ 0.55 (2.63%)
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 20.95 0.00 0.00 0.00 20.95 08:42:24
Bid Price Ask Price Spread Spread % News
21.30 24.79 3.49 14.08% - -
Stock Trades Traded Volume Average Volume 52 Week Range
4 460 1,212,685 7.26 - 26.59
Last Trade Time Type Quantity Stock Price Currency
08:13:13 formt 200 $ 21.50 USD

Iovance Biotherapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.59B 123.83M $ -123.58M -1.27 - 102.81M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Iovance Biotherapeutics News

Loading Messages....

Latest IOVA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IOVA Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week21.9822.2519.720520.84251M-1.03-4.69%
1 Month25.726.3519.720523.15121M-4.75-18.48%
3 Months17.2726.5916.12421.74012M3.6821.31%
6 Months10.3626.599.2117.13352M10.59102.22%
1 Year14.6526.597.2614.14831M6.343.00%
3 Years9.1826.594.4513.1030847k11.77128.21%
5 Years8.5726.594.2412.1497717k12.38144.46%

Iovance Biotherapeutics Description

Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient.


Your Recent History
NASDAQ
IOVA
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.